Hu5F9-G4: Phase I data

Data from 16 patients with solid tumors in a 2-part, open-label, dose-escalation U.S. Phase I

Read the full 154 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE